Nex Eye
Seoul
About Nex Eye
Nex Eye is a start-up that develops first-in-class antibodies targeting refractory factors of immuno-oncology drugs.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $63.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Aug 2025)
- Website: nex-i.co.kr
- Phone: +82-2-6951-0412
Industries & Categories
Medical, Oncology, Pharmaceutical
Canonical: https://fsome.com/organization/nex-eye-10572 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.